Vivien Santillan is a pharmaceutical and biopharmaceutical executive recognized for advancing regulatory excellence, digital transformation, and purposeful leadership. As Regional Director for Asia at Novatek International, she bridges deep technical expertise into business-ready strategies - assisting regulated organizations strengthen operational efficiency, data integrity, and compliance maturity. Her foundation in Computer Applications and certification in Total Quality Management strengthened her ability to align technology, quality, and regulatory expectations across diverse markets.
With expertise in GxP and quality systems digitalization, Vivien translates complex regulatory and technical requirements into clear, actionable strategies for executives, regulators, and cross-functional teams. Her work spans technical consulting, gap analysis, solution design, and high-impact communication—enabling companies to modernize operations while meeting global regulatory expectations.
Vivien plays active leadership role within ISPE, serving as Director at International Board, Chair of GAMP® South Asia Steering Committee, Past Chair of Women in Pharma® International Steering Committee and contributing to multiple Communities of Practice, including Drug Shortages and QC/Analytical. She envisions ISPE as a society that expands equitable access to relevant training and education and deepens its role as a strategic partner to affiliates, chapters and its members in navigating challenges and achieving their objectives for the pharmaceutical industry.
A respected mentor and advocate for women and emerging leaders, she integrates Asian leadership values with global best practices. Through cross-border engagements and thought leadership, she continues to build collaborative, sustainable communities across the life-sciences sector.
As I conclude my tenure as Chair of the Women in Pharma® International Steering Committee, I reflect on a journey that has been professionally enriching and personally transformative.
As Chair of ISPE’s Women in Pharma® International Steering Committee, I am proud to share a dynamic midyear update on the incredible momentum we have built together throughout 2025. This year has been marked by transformative progress, reinforcing our role as a driving force on leadership connection, and innovation across the global pharmaceutical community.
In the ever-evolving landscape of the pharmaceutical industry, the Women in Pharma® Steering Committee has taken significant steps to foster collaboration, share insights, and strengthen community engagement among the ISPE community. Over the past year, our commitment to these initiatives has opened doors for Women in Pharma Affiliate and Chapter leaders to connect, exchange best practices,...
As we approach the end of another impactful year, it is a pleasure to reflect on the outstanding achievements and contributions of ISPE’s Women in Pharma community, both regionally and internationally.
The 2024 ISPE Annual Meeting & Expo, taking place 13 – 16 October in Orlando, Florida, USA, and virtually, stands out as a key event in the pharmaceutical industry. Known for its rich educational offerings, the annual event serves as a dynamic platform where professionals gather...
The emergence of new modalities and innovations on drug development and research, such as advanced therapy medicinal products (ATMPs) and personalized and precise therapies, presents new opportunities for the treatment and management of diseases and injuries. As these innovations continue to evolve, the regulatory landscape likewise evolves and this has led to the production of higher-quality,...